Drs Manesh Patel and Amr Abbas begin our discussion by laying out the defining characteristic of peripheral artery disease (PAD) and how it compares to coronary artery disease (CAD).
Back
Optimizing Anticoagulation in Vascular Disease Patients: Reimagining the Standard of Care
A panel of experts discuss the diagnosis, management, and treatment options for peripheral artery disease (PAD), as well as what can be done to improve the treatment landscape.
Optimizing Anticoagulation in Vascular Disease Patients: Reimagining the Standard of Care
Episodes
All
All
Drs Larry Allen and Chris Granger highlight the common risk factors associated with the development of PAD.
Our panel delves into the PAD diagnosis process, room for improvement, and socioeconomic factors.
A panel of experts share common challenges with the management of patients with PAD in health systems.
Four professionals discuss roles for diet, exercise, and medications in managing patients with PAD.
Four experts explain their treatment selection strategies, as well as therapy options, for patients with PAD.
The panel introduces data from the COMPASS trial, including patient population and efficacy and safety data.
8The panel shares how data from the VOYAGER PAD trial made an impact in the PAD treatment landscape.
Dr Amr Abbas discusses management of major adverse limb events in PAD.
The panel concludes with final thoughts on how to improve outcome for patients with PAD.
Advertisement
Advertisement
Trending on HCPLive
1
AHA Publishes Results of Nationwide Initiative for Lp(a) Education and Awareness
2
Q&A: Upadacitinib Meets Primary Endpoint in Severe Alopecia Areata Trials
3
FDA Approves Glenmark’s Generic Fluticasone Propionate Nasal Spray
4
Left Atrial Strain Indicates Worse ATTR-CM Prognosis, but Attenuable With Vutrisiran
5